SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Frédéric Chopin

PatientFrédéric Chopin
Date of birth1998-03-01
IdentifiersMRN HR-NI020-SYN; SSN (made up) 000-20-8845
Document date2026-09-15
AuthorMatthias Lindqvist, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Mr. Chopin returns for his adult preventive visit eight weeks after completing tuberculosis treatment. He has had no cough, fever, night sweats, or weight loss since, and he has gained another 1.2 kg. He teaches his full schedule of about fifteen students a week and is preparing a small recital. He has a glass of wine with dinner a few times a week and has never smoked. His mood is good. He completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 28
Active conditionsPulmonary tuberculosis, treatment completed; malnutrition resolved
MedicinesNone since tuberculosis treatment ended
Functional statusIndependent; teaching full time

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, much better than in the spring
PsychosocialSupported by friends from home and by his students; he told his students about the illness and none left
BehavioralA glass of wine with dinner a few times a week (AUDIT-C 2); no tobacco or other drugs
NutritionThree meals and two snacks a day; no supplement drinks since August
Physical activityWalks about 30 minutes most days
Activities of daily livingIndependent in all
SleepAbout seven hours a night; no night sweats
SafetyNo firearms; smoke detector working; wears a seat belt
Hearing and visionNo concerns
Sexual healthDiscussed privately; no concerns

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight up; no fever or night sweats
EyesNegativeNo change in vision
Ears, nose, mouth, and throatNegativeNo sore throat or hoarseness
CardiovascularNegativeNo chest pain or palpitations
RespiratoryNegativeNo cough, sputum, hemoptysis, or breathlessness
GastrointestinalNegativeNo abdominal pain, greasy stools, or change in bowel habit
GenitourinaryNegativeNo urinary symptoms
MusculoskeletalNegativeNo tendon or joint pain
IntegumentaryNegativeNo rash
NeurologicalNegativeNo numbness or tingling in his fingers
PsychiatricNegativeMood good; PHQ-2 score 0

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Rifapentine 150 mg tablets, eight tablets (1200 mg) daily with food1200 mg once daily with a meal by video-observed therapy with the health department, seven days a week, for 17 weeks (119 doses)Oral route2026-03-20 to 2026-07-16completedS
Moxifloxacin 400 mg tablet, one tablet daily400 mg once daily with the other drugs by video-observed therapy with the health department, seven days a week, for 17 weeks; no mineral supplements within 4 hours before or 8 hours afterOral route2026-03-20 to 2026-07-16completedS
Isoniazid 300 mg tablet, one tablet daily300 mg once daily by video-observed therapy with the health department, seven days a week, for 17 weeksOral route2026-03-20 to 2026-07-16completedS
Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily1000 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phase (weight band 40 to under 55 kg)Oral route2026-03-20 to 2026-05-14completedS
Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily50 mg once daily with isoniazidOral route2026-03-20 to 2026-07-16completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-15Body height170cmS
2026-09-15Body weight56.2kgS
2026-09-15Body mass index (BMI) [Ratio]19.4kg/m2S
2026-09-15Systolic blood pressure112mm[Hg]S
2026-09-15Diastolic blood pressure70mm[Hg]S
2026-09-15Heart rate70/minS
2026-09-15Respiratory rate14/minS
2026-09-15Body temperature36.6CelS
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-15Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-09-15Total score [AUDIT-C]2{score}S

Physical Exam

Vital signs recorded on 2026-09-15; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; slim; BMI 19.4
EyesConjunctivae normal
Ears, nose, and throatNormal; no nasal polyps
NeckNo lymph nodes
CardiovascularRegular rhythm; no murmur
RespiratoryClear; no crackles
AbdomenSoft; liver not enlarged
ExtremitiesNo clubbing
SkinNo rash or suspicious lesions
NeurologicalNormal sensation and fine finger movements

Problems

ProblemClinical statusVerificationCodeProvenance
Cough for about three months, blood-streaked sputum for two weeks, night sweats, and weight loss of about 6 kg in a man of 28, with a right upper lobe cavity on chest X-ray and CT: suspected pulmonary tuberculosis; home airborne isolation and three sputum samples for acid-fast smear, nucleic acid amplification, and cultureresolvedconfirmed R04.2S — Synthetic presenting problem linked to his documented chronic cough and hemoptysis; superseded by the diagnosis at the second visit.
Pulmonary tuberculosis of the right upper lobe, cavitary and sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistanceactiveconfirmed A15.0S — Synthetic modern coding of his documented tuberculosis, chosen over the disputed genetic and cardiac alternatives; the cavity and all bacteriology are synthetic.
Moderate protein-calorie malnutrition: BMI 16.8, about 11 percent weight loss in three months, and albumin 3.2 g/dLresolvedconfirmed E44.0S — Synthetic nutrition diagnosis anchored to his documented frailty and exhaustion.
Acute viral upper respiratory infection during the continuation phase of tuberculosis treatment; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness chosen to teach how to tell a cold from tuberculosis treatment failure, and moxifloxacin interactions with cold remedies; it does not echo a documented illness.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 2026-2027Completed todayGiven today
COVID-19 vaccine, 2026-2027DueRecommended; he will get it at his pharmacy
Tetanus, diphtheria, and pertussis boosterUp to dateTdap about three years ago
Hepatitis B vaccineUp to dateImmune by surface antibody at the tuberculosis diagnosis
HPV vaccineUp to dateSeries completed in adolescence by his report
HIV screeningUp to dateNegative at the tuberculosis diagnosis
Hepatitis C screeningUp to dateAntibody negative at the tuberculosis diagnosis
Tuberculosis testingNot indicatedTreated for active tuberculosis; the blood test stays positive; symptom review instead
Depression screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol use screeningCompleted todayAUDIT-C 2, below the risk threshold
Tobacco useCompleted todayNever used
Blood pressure screeningCompleted today112/70 mmHg
Diabetes screeningNot indicatedRecommended from 35 for adults with overweight or obesity; BMI 19.4
Sexual health and STI screeningCompleted todayDiscussed privately; no screening indicated by his history

Immunizations given today: Influenza vaccine, 2026-2027 season [S]

Guideline basis: Depression and Suicide Risk in Adults: Screening (2023); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Next preventive visit in one year; same-day visit for symptoms of relapse. [S]

Advance Care Planning

Brief voluntary discussion, offered because of this year's serious illness. He wants to think about whom to name as his health care agent and was given the state's health care directive form. No treatment preferences are recorded. [S]